| Outcome Measures: |
Primary: HbA1c, Changes from baseline glycated hemoglobin levels at 12 weeks, baseline and 12 weeks | Secondary: Fasting glucose, Changes from baseline fasting glucose levels at 12 weeks, baseline and 12 weeks|Insulin levels, Changes from baseline insulin levels at 12 weeks, baseline and12 weeks|Total serum cholesterol (CT) and fractions, Changes from baseline total serum cholesterol, high-density lipoprotein (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels at 12 weeks, baseline and12 weeks|Triglycerides serum levels, Changes from baseline triglycerides serum levels at 12 weeks, baseline and12 weeks|Glucose variability, Changes in glucose levels throughout the day assessed by a continuous glucose monitoring system (CGMS), for 2 weeks (10-12th week)|Cytokine levels, Changes from baseline TNF-α, IL-1, IL-6 levels at 12 weeks, baseline and 12 weeks|Protein creatine index, Changes from baseline protein creatinine index measured in urine at 12 weeks., baseline and 12 weeks|Albuminuria, Changes from baseline albuminuria levels at 12 weeks, baseline and 12 weeks|Body mass index (BMI), Changes from baseline BMI calculated by weight (kg) and height (cm) at 4, 8, and 12 weeks., baseline and 4, 8, and 12 weeks
|
